Abstract:Guocan Yu, 1 Yanqin Shen, 2 Liwei Yao, 2 Xudong Xu 1 1 Zhejiang Tuberculosis Diagnosis and Treatment Center, Hangzhou Red Cross Hospital, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Nursing, Hangzhou Red Cross Hospital, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China Correspondence: Liwei Yao; Xudong Xu, Email ; Purpose: This study aimed to evaluate the efficacy of nanopore sequencing for diagnosing pulmonary tuberculosis (PTB) using smear-negative clinical specimens. Methods: We conducted a retrospective study based on a review of patient medical records to assess the accuracy of nanopore sequencing as a diagnostic tool for smear-negative PTB. Compared with clinical diagnosis, we determined the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) of nanopore sequencing. Results: A total of 647 patients were evaluated. Nanopore sequencing demonstrated an overall sensitivity of 91.7%, specificity of 85.3%, PPV of 95.1%, NPV of 76.4%, and AUC of 0.88. Notably, the overall diagnostic accuracy of nanopore sequencing was significantly higher than that of Mycobacterium tuberculosis (MTB) culture technique. Conclusion: Nanopore sequencing exhibited satisfactory overall diagnostic accuracy for smear-negative PTB, regardless of MTB culture status. Therefore, if conditions permit, nanopore sequencing is recommended as a diagnostic method for smear-negative PTB. Keywords: nanopore sequencing, smear-negative specimens, pulmonary tuberculosis, diagnostic accuracy Tuberculosis (TB) is a highly contagious disease caused by Mycobacterium tuberculosis (MTB), which continues to pose threats in the field of global health, as indicated by recent statistical data. 1 In 2022, 10.6 million new TB diagnoses and 1.3 million TB deaths were recorded worldwide. 1 Consequently, TB ranked among the top 10 causes of death attributed to a single infectious disease. 2 The most prevalent form of TB is pulmonary TB (PTB), accounting for approximately 70–85% of all TB cases. 3 PTB serves as the primary source of TB transmission. 4 Therefore, controlling the source of infection is crucial for reducing the spread of TB. Effective detection and treatment of PTB are key for controlling the source of infection effectively. Acid-fast bacilli (AFB) smear is the most widely used clinical method for diagnosing PTB. 5 However, it exhibits low sensitivity, indicating that a large proportion of patients present with a negative AFB smear. 6 Smear-negative PTB cases are easily overlooked, resulting in PTB transmission. 2 Improving the diagnostic accuracy of PTB using smear-negative clinical specimens remains a major challenge. Although MTB culture technique is essential for PTB diagnosis, it requires a long time and cannot facilitate early diagnosis. 7 Moreover, smear-negative PTB specimens may exhibit lower MTB content than smear-positive PTB specimens, resulting in a reduced culture positivity rate. 8 Consequently, relying solely on MTB culture technique for diagnosing smear-negative PTB may have limited efficacy. 9 The development of molecular diagnostic techniques in recent years has led to significant advancements in the rapid diagnosis of infectious diseases, including TB. 10,11 Xpert MTB/RIF is the most widely used molecular test for rapid diagnosis of TB recommended by the World Health Organization, also in China. 12 However, its accuracy in paucibacillary TB diagnosis still needs to be further improved. 13 Genetic sequencing is widely used in the field of infectious diseases and offers unique advantages for the rapid diagnosis of TB. 13,14 The utilization of next-generation sequencing (NGS) in TB has demonstrated remarkable diagnostic efficacy, thereby greatly improving TB diagnosis. 15 Nanopore sequencing is a unique and scalable technology that monitors changes in the current of nucleic acids as they pass through nanopore proteins. The resulting signal is decoded to provide specific DNA or RNA sequences. 16 Nanopore sequencing offers portability, real-time analysis, and long read lengths compared with other NGS techniques. 17,18 Its ability to directly detect and decode genetic material with high accuracy and efficiency will undoubtedly revolutionize various fields of research and significantly contribute to advancements in personalized medicine and molecular biology. I -Abstract Truncated-

Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease

The Application of Nanopore Targeted Sequencing for Pathogen Diagnosis in Bronchoalveolar Lavage Fluid of Patients with Pneumonia: a Prospective Multicenter Study.

Study on the early diagnostic value of nanopore sequencing in alveolar lavage fluid smear-negative pulmonary tuberculosis

A preliminary evaluation of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis in bronchoalveolar lavage fluid specimens

Clinical application of nanopore-targeted sequencing technology in bronchoalveolar lavage fluid from patients with pulmonary infections

Accuracy of Nanopore Sequencing as a Diagnostic Assay for Pulmonary Tuberculosis versus Smear, Culture and Xpert MTB/RIF: A Head-to-Head Comparison

Illumina and Nanopore sequencing in culture-negative samples from suspected lower respiratory tract infection patients

Nanopore sequencing for smear-negative pulmonary tuberculosis—a multicentre prospective study in China

Diagnostic Accuracy of Nanopore Sequencing Using Respiratory Specimens in the Diagnosis of Pulmonary Tuberculosis.

Diagnostic Value of Targeted Next-generation Sequencing in Pulmonary Mycobacterial Infections

Evaluation of Nanopore Sequencing for Diagnosing Pulmonary Tuberculosis Using Negative Smear Clinical Specimens

Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease

Diagnostic Performance of Metagenomic Next-Generation Sequencing in Non-Tuberculous Mycobacterial Pulmonary Disease when Applied to Clinical Practice

Diagnostic value of nucleic acid amplification tests on bronchoalveolar lavage fluid for smear-negative pulmonary tuberculosis: a meta-analysis.

Using cerebrospinal fluid nanopore sequencing assay to diagnose tuberculous meningitis: a retrospective cohort study in China

Metagenomic next generation sequencing of bronchoalveolar lavage fluids for the identification of pathogens in patients with pulmonary infection: A retrospective study

Nanopore Sequencing Technology: A Reliable Method for Pathogen Diagnosis in Elderly Patients with Community-Acquired Pneumonia

Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis

Improved Targeting of the 16S Rdna Nanopore Sequencing Method Enables Rapid Pathogen Identification in Bacterial Pneumonia in Children.

Cellular analysis and metagenomic next-generation sequencing of bronchoalveolar lavage fluid in the distinction between pulmonary non-infectious and infectious disease

Prospective evaluation of nanopore-based metagenomic sequencing for rapid detection of bacterial pathogens in patients with lower respiratory tract infections